Connect with us
[ad_1] Corrections & Amplifications This headline was corrected at 0731 GMT to reflect GSK PLC 4Q Pre-Items, Pre-Tax Pft GBP1.56B, not GBP8.11B Corrections & Amplifications This...
[ad_1] Pfizer Stock Gains After Earnings Beat. Revenue and Outlook Aren’t So Good. [ad_2] Source link
[ad_1] By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients with relapsed or refractory multiple myeloma didn’t meet its primary...